Malaria research and its influence on anti-malarial drug policy in Malawi: a case study

BACKGROUND: In 1993, Malawi changed its first-line anti-malarial treatment for uncomplicated malaria from chloroquine to sulfadoxine-pyrimethamine (SP), and in 2007, it changed from SP to lumefantrine-artemether. The change in 1993 raised concerns about whether it had occurred timely and whether it...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Health Res Policy Syst
Asıl Yazarlar: Mwendera, Chikondi, de Jager, Christiaan, Longwe, Herbert, Phiri, Kamija, Hongoro, Charles, Mutero, Clifford M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4888534/
https://ncbi.nlm.nih.gov/pubmed/27246503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12961-016-0108-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller